Partner David Rosen, who chairs the firm’s FDA regulatory practice, was quoted in a Law360 article, “FDA Focus: What Foley & Lardner’s Practice Chair is Watching,” about litigation and regulation he’s watching, the skills he looks for when hiring an FDA lawyer and the one FDA policy he’d change if he had a magic wand.
Rosen said the firm does a lot of work with compliance and enforcement, especially with data integrity issues. He also said he’s always been a “stickler” about making sure products meet appropriate standards of identity, strength, quality and purity at the time of use.
People
Related News
April 13, 2026
In the News
Increase in Demand and Firm Growth Led Foley to Large Leaps in Revenue and PEP in a 'Year When It All Came Together'
Foley & Lardner LLP saw double-digit increases and all-time highs across all financial metrics in 2025 as noted in The American Lawyer article, “Foley Grows Revenue by Nearly 14%, PEP by 27%, in a 'Year When It All Came Together'.”
April 10, 2026
In the News
Foley's Texas Media Roundtable Highlighted for Insights on Today's Energy Transformations
Foley & Lardner LLP is featured across media for the firm’s recent roundtable discussion on energy trends related to grid reliability, data centers, and capital investments.
April 10, 2026
In the News
Deanna Reitman and Glenn Reitman Highlighted Across Media for Foley Arrival
Foley & Lardner LLP partners Deanna Reitman and Glenn Reitman attracted widespread media coverage for their recent arrival to the firm’s Houston office.